The supply planning challenge

In biologics and Advanced Therapy Medicinal Product (ATMP) supply chains, demand is only half of the planning equation. Good demand planning has a single organizing goal, to make every source of demand visible in one consolidated, time-phased picture. Supply planning is the mirror image of that discipline. Its organizing goal is to make every source of supply visible with the same rigor, covering what your suppliers and CDMOs can deliver, what you already hold in inventory, and what your manufacturing network can actually produce.

This article opens a three-part series on supply planning. It frames the core challenge, that supply in this sector is chronically constrained and the information describing it is chronically scattered, and it introduces the three sources of supply that the remaining articles develop in detail. As with demand planning, the discipline is less about sophisticated math than about gathering, organizing, and maintaining inputs in a simple, repeatable, scalable way.

Supply is scarce, and its signals are scattered

Biologics and ATMP supply chains are defined by scarcity. Whether the binding constraint is manufacturing capacity at a CDMO, the availability of a single-sourced starting material, or the finite shelf life of a cryopreserved drug product, there is rarely enough supply to absorb every demand signal at once. That scarcity is why the quality of your supply information matters. When supply is abundant, imprecise data is forgiving. When every unit is contested, a stale cycle time or an unmonitored expiry can delay a patient’s therapy.

The difficulty is that the information describing supply does not live in one place. Procurement holds vendor lead times. Quality holds release timelines. Manufacturing and Engineering hold yield assumptions and the true rate-limiting step. Warehouses and CDMOs hold the real, current inventory position and its expiry profile. Each of these is a genuine source of supply, and each is typically maintained by a different function on a different cadence. Left unconsolidated, they never form a coherent picture of what is actually available to plan against.

The three sources of supply

Just as demand planning resolves into three distinct streams (commercial, clinical, and analytical), supply planning resolves into three distinct sources. Each answers a different question about what you can rely on, and each carries its own failure mode when managed in isolation.

These three sources line up with the three core disciplines of supply management, which are supplier management, inventory management, and capacity management. The remaining articles take each in turn. Part 2 covers the supply you procure and hold (suppliers, CDMO governance, and inventory), and Part 3 covers the supply you produce (capacity and planning horizons) before bringing all three together into a unified supply picture that can be netted against demand.

Characterizing supply by phase

Gathering the three sources is necessary but not sufficient. A second dimension must be captured alongside quantity and timing. That dimension is the qualification and phase status of each source of supply, because not all supply is fungible against all demand. Two units at the same BOM level, expressed in the same UOM, may not be interchangeable. Registered commercial material is not what an early-phase study needs, and pre-PPQ or engineering material cannot satisfy a commercial demand.

The discipline is to characterize every source of supply by its status (pre-PPQ or engineering material, post-PPQ material, and registered commercial supply, along with its process version and manufacturing site) and to record, for every demand, the status that can satisfy it. Clinical demand for pivotal and Phase 3 studies typically requires post-PPQ material, commercial demand can be satisfied only by registered, process-validated commercial supply, and early-phase clinical demand can draw on earlier-phase material. Capturing this eligibility is part of gathering supply. Enforcing it, by netting only eligible supply against eligible demand, belongs to the balancing step that follows.

A mise-en-place for supply

The Demand and Supply Management disciplines are, in effect, a mise-en-place for your integrated plan, with every ingredient organized, current, and within reach before the cooking begins. For supply, that means each source is captured in an agreed unit of measure (UOM), tied to the correct level of the Bill of Material (BOM), and stored where the broader planning team can access and trust it. Consistency of UOM and BOM level across supply and demand is what later allows the two to be netted against each other at all.

It is the supply-side counterpart to the demand register many planning teams already keep, a single, shared, time-phased record of available supply (inbound procurement, on-hand inventory, and committed capacity) maintained on a regular cycle rather than reconstructed under pressure. Building and maintaining that record is the practical heart of supply planning.

Horizon and cadence

A sound planning framework holds to three core principles regardless of company maturity. The first is an emphasis on simplicity, repeatability, and standardization. The second is a planning horizon that extends a minimum of 36 months. The third is a monthly planning cycle built around a variant of Sales & Operations Planning (S&OP), Sales & Operations Execution (S&OE), or Integrated Business Planning (IBP). These principles apply to supply exactly as they apply to demand.

A 36-month horizon is essential on the supply side because the lead times that govern biologics and ATMP supply (CDMO capacity reservations, long-lead single-sourced materials, and the qualification of new sources) routinely stretch well beyond a single year. Gathering supply only for the near term guarantees that long-lead constraints surface too late to act on. The monthly cadence is what keeps the supply picture current as yields, expiries, and cycle times change, which, in this sector, they continually do.

What comes next

The rest of this series is about doing the gathering well. Part 2 examines the supply you procure and hold, covering how to capture and monitor supplier cycle times at every BOM level, how to structure CDMO governance so that a rolling forecast earns reliable capacity, and how to set inventory strategies and monitor expiries so that on-hand material is real supply rather than latent write-off. Part 3 completes the picture with capacity management and planning-horizon alignment, then shows how the three sources are netted into a single supply view ready to be balanced against demand.

The premise throughout is simple. In constrained, high-stakes supply chains, it is the disciplined capture of ordinary information, not clever optimization, that determines whether patients receive their therapy on time.